Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahram Mofid

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Phytotherapy Research : PTR|November 15, 2018
Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapyAfshin Saadipoor, Abolfazl Razzaghdoust, Nasser Simforoosh, et al.
Journal of Cancer Research and Therapeutics|June 14, 2021
Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A reviewMastaneh Sanei, Hamed Ghaffari, Mahdieh Afkhami Ardekani, et al.
Journal of Medical Imaging and Radiation Sciences|June 10, 2019
MRI Radiomic Analysis of IMRT-Induced Bladder Wall Changes in Prostate Cancer Patients: A Relationship with Radiation Dose and ToxicityHamid Abdollahi, Kiarash Tanha, Bahram Mofid, et al.
The Prostate|July 23, 2025
Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy-Induced Dysuria in Prostate Cancer Patients: A Randomized Placebo-Controlled TrialVida Nazari, Omid Keshavarzian, Mehdi Pasalar, et al.
Investigative and Clinical Urology|May 4, 2021
Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancerAbolfazl Razzaghdoust, Mahdi Ghajari, Abbas Basiri, et al.
Urology Journal|March 5, 2022
Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective AnalysisBahram Mofid, Abolfazl Razzaghdoust, Mahdi Ghajari, et al.
Clinical and Translational Radiation Oncology|February 4, 2025
Fully automatic reconstruction of prostate high-dose-rate brachytherapy interstitial needles using two-phase deep learning-based segmentation and object tracking algorithmsMohammad Mahdi Moradi, Zahra Siavashpour, Soheib Takhtardeshir, et al.
La Radiologia Medica|January 5, 2019
Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancerHamid Abdollahi, Bahram Mofid, Isaac Shiri, et al.
BMC Urology|May 25, 2026
Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort studyBahram Mofid, Anya Jafari, Nasser Simforoosh, et al.
World Journal of Nuclear Medicine|September 14, 2019
Efficacy and safety of <sup>177</sup>Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia - A prospective studyRamin Akbarian Aghdam, Mahasti Amoui, Mohammadali Ghodsirad, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Phytotherapy Research : PTR|November 15, 2018
Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapyAfshin Saadipoor, Abolfazl Razzaghdoust, Nasser Simforoosh, et al.
Journal of Cancer Research and Therapeutics|June 14, 2021
Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A reviewMastaneh Sanei, Hamed Ghaffari, Mahdieh Afkhami Ardekani, et al.
Journal of Medical Imaging and Radiation Sciences|June 10, 2019
MRI Radiomic Analysis of IMRT-Induced Bladder Wall Changes in Prostate Cancer Patients: A Relationship with Radiation Dose and ToxicityHamid Abdollahi, Kiarash Tanha, Bahram Mofid, et al.
The Prostate|July 23, 2025
Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy-Induced Dysuria in Prostate Cancer Patients: A Randomized Placebo-Controlled TrialVida Nazari, Omid Keshavarzian, Mehdi Pasalar, et al.
Investigative and Clinical Urology|May 4, 2021
Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancerAbolfazl Razzaghdoust, Mahdi Ghajari, Abbas Basiri, et al.
Urology Journal|March 5, 2022
Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective AnalysisBahram Mofid, Abolfazl Razzaghdoust, Mahdi Ghajari, et al.
Clinical and Translational Radiation Oncology|February 4, 2025
Fully automatic reconstruction of prostate high-dose-rate brachytherapy interstitial needles using two-phase deep learning-based segmentation and object tracking algorithmsMohammad Mahdi Moradi, Zahra Siavashpour, Soheib Takhtardeshir, et al.
La Radiologia Medica|January 5, 2019
Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancerHamid Abdollahi, Bahram Mofid, Isaac Shiri, et al.
BMC Urology|May 25, 2026
Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort studyBahram Mofid, Anya Jafari, Nasser Simforoosh, et al.
World Journal of Nuclear Medicine|September 14, 2019
Efficacy and safety of <sup>177</sup>Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia - A prospective studyRamin Akbarian Aghdam, Mahasti Amoui, Mohammadali Ghodsirad, et al.
Pageof 5